Columbus Venture Partners

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds

1

Reported volume

€220m

Latest public closing

18 Jun 2026

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

Spanish life sciences venture capital firm investing in early-stage and growth companies.

Focus: Early-stage and growth investments in life sciences, including biotechnology, medical technology, pharmaceuticals and healthcare

May 2024: Columbus Life Sciences Fund IV closed at about $164.9m (fund database; first or final close not specified).